Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions

Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions

Abstract Alzheimer's disease (AD), a neurodegenerative disease leading to dementia, lacks a single definitive diagnosis. While current medications only manage symptoms, the ideal treatment would restore cognition. Traditional therapies targeting beta‐amyloid haven't yielded significant res...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tapas Kumar Mohapatra, Reena Rani Nayak, Ankit Ganeshpurkar, Prashant Tiwari, Dileep Kumar
Format:	Article
Language:	English
Published:	Wiley-VCH 2025-06-01
Series:	Ibrain
Subjects:	Alzheimer's disease neurofibrillary tangles N‐methyl‐D aspartate receptors presenilin β‐amyloid
Online Access:	https://doi.org/10.1002/ibra.12197
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The evolution of Alzheimer’s disease therapies: A comprehensive review
by: Pritama Paul, et al.
Published: (2024-01-01)

Role of Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Clinical Diagnosed Alzheimer’s Diseases
by: Dilip Raj Timalsina, et al.
Published: (2025-05-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01)

Impaired glymphatic clearance is an important cause of Alzheimer’s disease
by: Iyawnna Hazzard, et al.
Published: (2024-10-01)

The role of neuroimaging in Alzheimer’s disease: implications for the diagnosis, monitoring disease progression, and treatment
by: Julius Mulumba, et al.
Published: (2025-02-01)

Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms
by: Souvik Adak, et al.
Published: (2025-08-01)

Inhibitory potential of polyphenolic stilbene derivatives with Glycogen Synthase Kinase-3β (GSK-3β) for Alzheimer's disease: Computational and SAR insights
by: Santosh Prasad Chaudhary Kurmi, et al.
Published: (2025-03-01)

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
by: Tsu-Kung Lin, et al.
Published: (2024-11-01)

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease
by: Guo Y, et al.
Published: (2016-02-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Inspecting the potential of thymol as a therapeutic agent for treating Alzheimer's disease
by: Muhammad Waleed Imran, et al.
Published: (2024-10-01)

Traumatic brain injury as a precursor to neurodegenerative diseases: Mechanisms linking TBI to Alzheimer’s disease
by: Kirti Bamel, et al.
Published: (2025-06-01)

Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
by: Benedikt Kretner, et al.
Published: (2016-03-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
by: Julia C. Colwell, et al.
Published: (2025-07-01)

Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01)

Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling
by: Anna M. Timofeeva, et al.
Published: (2025-05-01)

The past, present and future of Alzheimer's disease – part 1: the past
by: Ricardo Nitrini
Published: (2023-12-01)

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition
by: Jie Xiang, et al.
Published: (2025-05-01)

Spectrum of γ-Secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes
by: Sara Gutiérrez Fernández, et al.
Published: (2025-04-01)

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
by: Divya Bali, et al.
Published: (2025-06-01)

γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds
by: Johannes Trambauer, et al.
Published: (2025-02-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

PF-06447475 Molecule Attenuates the Neuropathology of Familial Alzheimer’s and Coexistent Parkinson’s Disease Markers in PSEN1 I416T Dopaminergic-like Neurons
by: Diana Alejandra Quintero-Espinosa, et al.
Published: (2025-05-01)

Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues
by: Peizhou Jiang, et al.
Published: (2025-03-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Identification of presenilin mutations that have sufficient gamma-secretase proteolytic activity to mediate Notch signaling but disrupt organelle and neuronal health
by: Zahra Ashkavand, et al.
Published: (2025-08-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors
by: Maricarmen Hernández-Rodríguez, et al.
Published: (2025-03-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Lecanemab for mild Alzheimer disease – is there a way forward?
by: Rajesh R Tampi
Published: (2025-03-01)

Chaperone-Mediated Responses and Mitochondrial–Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer’s Disease
by: Manish Kumar Singh, et al.
Published: (2025-07-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

The role of monocytes and macrophages in the progression of Alzheimer’s disease
by: Wenyi Nie, et al.
Published: (2025-04-01)

Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

No evidence of Alzheimer’s disease pathology in mice infected with Toxocara canis
by: Vosála Ondřej, et al.
Published: (2025-01-01)